Erol K. Bayburt

1.7k total citations
17 papers, 964 citations indexed

About

Erol K. Bayburt is a scholar working on Organic Chemistry, Molecular Biology and Sensory Systems. According to data from OpenAlex, Erol K. Bayburt has authored 17 papers receiving a total of 964 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Organic Chemistry, 8 papers in Molecular Biology and 6 papers in Sensory Systems. Recurrent topics in Erol K. Bayburt's work include Synthesis and Reactivity of Heterocycles (6 papers), Ion Channels and Receptors (6 papers) and Pain Mechanisms and Treatments (5 papers). Erol K. Bayburt is often cited by papers focused on Synthesis and Reactivity of Heterocycles (6 papers), Ion Channels and Receptors (6 papers) and Pain Mechanisms and Treatments (5 papers). Erol K. Bayburt collaborates with scholars based in United States, United Kingdom and Switzerland. Erol K. Bayburt's co-authors include Arthur Gomtsyan, Prisca Honoré, Connie R. Faltynek, Heath A. McDonald, Kennan C. Marsh, James P. Sullivan, Michael F. Jarvis, Michael Capparelli, Lawrence MacPherson and Lijuan Zhu and has published in prestigious journals such as Journal of Neuroscience, Journal of Medicinal Chemistry and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Erol K. Bayburt

17 papers receiving 930 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Erol K. Bayburt United States 15 348 282 261 227 202 17 964
Stefania Baraldi Italy 18 398 1.1× 91 0.3× 370 1.4× 67 0.3× 63 0.3× 29 906
Qin Tong China 16 409 1.2× 457 1.6× 49 0.2× 83 0.4× 56 0.3× 35 957
Charlotte Dubois France 13 303 0.9× 200 0.7× 58 0.2× 53 0.2× 72 0.4× 21 766
Thorsten J. Maier Germany 14 247 0.7× 70 0.2× 64 0.2× 57 0.3× 124 0.6× 24 670
Bernard P. Kok United States 15 681 2.0× 56 0.2× 103 0.4× 186 0.8× 70 0.3× 23 1.1k
Laxmikant A. Gharat India 12 148 0.4× 150 0.5× 151 0.6× 62 0.3× 27 0.1× 29 472
Gregory J. Hollingworth United Kingdom 16 336 1.0× 90 0.3× 316 1.2× 70 0.3× 37 0.2× 31 726
Diana Vara‐Ciruelos Spain 15 505 1.5× 111 0.4× 43 0.2× 67 0.3× 86 0.4× 18 814
Woo Young Chung South Korea 13 461 1.3× 418 1.5× 20 0.1× 117 0.5× 44 0.2× 48 1.0k
Jocelyn Céraline France 18 597 1.7× 137 0.5× 24 0.1× 34 0.1× 148 0.7× 35 1.1k

Countries citing papers authored by Erol K. Bayburt

Since Specialization
Citations

This map shows the geographic impact of Erol K. Bayburt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erol K. Bayburt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erol K. Bayburt more than expected).

Fields of papers citing papers by Erol K. Bayburt

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Erol K. Bayburt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erol K. Bayburt. The network helps show where Erol K. Bayburt may publish in the future.

Co-authorship network of co-authors of Erol K. Bayburt

This figure shows the co-authorship network connecting the top 25 collaborators of Erol K. Bayburt. A scholar is included among the top collaborators of Erol K. Bayburt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Erol K. Bayburt. Erol K. Bayburt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Schmidt, Robert G., Erol K. Bayburt, Steven P. Latshaw, et al.. (2011). Chroman and tetrahydroquinoline ureas as potent TRPV1 antagonists. Bioorganic & Medicinal Chemistry Letters. 21(5). 1338–1341. 35 indexed citations
2.
Surowy, Carol S., Torben R. Neelands, Bruce R. Bianchi, et al.. (2008). (R)-(5-tert-Butyl-2,3-dihydro-1 H-inden-1-yl)-3-(1 H-indazol-4-yl)-urea (ABT-102) Blocks Polymodal Activation of Transient Receptor Potential Vanilloid 1 Receptors in Vitro and Heat-Evoked Firing of Spinal Dorsal Horn Neurons in Vivo. Journal of Pharmacology and Experimental Therapeutics. 326(3). 879–888. 38 indexed citations
3.
Gomtsyan, Arthur, Erol K. Bayburt, Robert G. Schmidt, et al.. (2008). Identification of (R)-1-(5-tert-Butyl-2,3-dihydro-1H-inden-1-yl)-3-(1H-indazol-4-yl)urea (ABT-102) as a Potent TRPV1 Antagonist for Pain Management. Journal of Medicinal Chemistry. 51(3). 392–395. 65 indexed citations
4.
Gomtsyan, Arthur, Erol K. Bayburt, Ryan G. Keddy, et al.. (2007). α-Methylation at benzylic fragment of N-aryl-N′-benzyl ureas provides TRPV1 antagonists with better pharmacokinetic properties and higher efficacy in inflammatory pain model. Bioorganic & Medicinal Chemistry Letters. 17(14). 3894–3899. 26 indexed citations
5.
Cui, Minghua, Prisca Honoré, Chengmin Zhong, et al.. (2006). TRPV1 Receptors in the CNS Play a Key Role in Broad-Spectrum Analgesia of TRPV1 Antagonists. Journal of Neuroscience. 26(37). 9385–9393. 252 indexed citations
6.
Drizin, Irene, Arthur Gomtsyan, Erol K. Bayburt, et al.. (2006). Structure–activity studies of a novel series of 5,6-fused heteroaromatic ureas as TRPV1 antagonists. Bioorganic & Medicinal Chemistry. 14(14). 4740–4749. 24 indexed citations
7.
Perner, Richard J., Stanley DiDomenico, Erol K. Bayburt, et al.. (2005). Synthesis and biological evaluation of 6,7-disubstituted 4-aminopyrido[2,3-d]pyrimidines as adenosine kinase inhibitors. Bioorganic & Medicinal Chemistry Letters. 15(11). 2803–2807. 29 indexed citations
8.
Gfesser, Gregory A., Erol K. Bayburt, Marlon Cowart, et al.. (2003). Synthesis and structure-activity relationships of 5-heteroatom-substituted pyridopyrimidines as adenosine kinase inhibitors. European Journal of Medicinal Chemistry. 38(3). 245–252. 31 indexed citations
9.
Perner, Richard J., Erol K. Bayburt, Karen M. Alexander, et al.. (2003). 5,6,7-Trisubstituted 4-Aminopyrido[2,3-d]pyrimidines as Novel Inhibitors of Adenosine Kinase. Journal of Medicinal Chemistry. 46(24). 5249–5257. 21 indexed citations
10.
Cowart, Marlon, Gregory A. Gfesser, Erol K. Bayburt, et al.. (2001). Structure–activity studies of 5-substituted pyridopyrimidines as adenosine kinase inhibitors. Bioorganic & Medicinal Chemistry Letters. 11(1). 83–86. 24 indexed citations
11.
Hajduk, Philip J., Arthur Gomtsyan, Stanley DiDomenico, et al.. (2000). Design of Adenosine Kinase Inhibitors from the NMR-Based Screening of Fragments. Journal of Medicinal Chemistry. 43(25). 4781–4786. 46 indexed citations
12.
13.
Gu, Yu, Erol K. Bayburt, Michael R. Michaelides, Chun Wei Lin, & Kazumi Shiosaki. (1999). trans-2,6-, 3,6- and 4,6-Diaza-5,6,6a,7,8,12b-hexahydrobenzo[C]phenanthrene-10,11-diols as dopamine agonists. Bioorganic & Medicinal Chemistry Letters. 9(10). 1341–1346. 5 indexed citations
14.
MacPherson, Lawrence, Erol K. Bayburt, Michael Capparelli, et al.. (1997). Discovery of CGS 27023A, a Non-Peptidic, Potent, and Orally Active Stromelysin Inhibitor That Blocks Cartilage Degradation in Rabbits. Journal of Medicinal Chemistry. 40(16). 2525–2532. 288 indexed citations
15.
Michaelides, Michael R., Stanley DiDomenico, Erol K. Bayburt, et al.. (1997). Substituted Hexahydrobenzo[f]thieno[c]quinolines as Dopamine D1-Selective Agonists:  Synthesis and Biological Evaluation in Vitro and in Vivo. Journal of Medicinal Chemistry. 40(11). 1585–1599. 35 indexed citations
16.
17.
MacPherson, Lawrence, Erol K. Bayburt, Michael Capparelli, et al.. (1993). Design and synthesis of an orally active macrocyclic neutral endopeptidase 24.11 inhibitor. Journal of Medicinal Chemistry. 36(24). 3821–3828. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Stefania Baraldi Breakdown of academic impact, for papers by Qin Tong Breakdown of academic impact, for papers by Charlotte Dubois Breakdown of academic impact, for papers by Thorsten J. Maier Breakdown of academic impact, for papers by Bernard P. Kok Breakdown of academic impact, for papers by Laxmikant A. Gharat Breakdown of academic impact, for papers by Gregory J. Hollingworth Breakdown of academic impact, for papers by Diana Vara‐Ciruelos Breakdown of academic impact, for papers by Woo Young Chung Breakdown of academic impact, for papers by Jocelyn Céraline
Rankless by CCL
2026